A pooled analysis of clinical outcomes with anti-PD1-based neoadjuvant immunotherapy (NeoIT) in cutaneous squamous cell carcinoma (cSCC).
Year: 2025
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Ines Esteves Domingues Pires da Silva, Vincent The-Luc Ma, Susmita Reddy Karri, Michael Lowe, Ronen Stoff, Andrea Boutros, Nessr Abu Rached, Samrin Liaqat, Teresa Amaral, Charlee Nardin, Janice M. Mehnert, Caroline Gaudy-Marqueste, Eva Muñoz Couselo, Christian B. Agbisit, Ignasi Martim, Lucie Heinzerling, Matthew Stephen Block, Matteo S. Carlino, Serigne N. Lo, Karam Khaddour
Institutions: The University of Sydney, Melanoma Institute Australia, University of Wisconsin–Madison, Blacktown & Mount Druitt Hospital, Westmead Hospital, Emory University, Mayo Clinic, University of Genoa, Ruhr University Bochum, Fiona Stanley Hospital, University of Tübingen, Inserm, Centre Hospitalier Universitaire de Besançon, Interactions Hôte-Greffon-Tumeur & Ingénierie Cellulaire et Génique, Université de Franche-Comté, NYU Langone Health, NYU Langone’s Laura and Isaac Perlmutter Cancer Center, New York University, Aix-Marseille Université, Hôpital de la Timone, Vall d'Hebron Institute of Oncology, Georgetown University Medical Center, Georgetown Lombardi Comprehensive Cancer Center, Hospital Clínic de Barcelona, Ludwig-Maximilians-Universität München, Mayo Clinic Comprehensive Cancer Center (Minnesota), Dana-Farber Cancer Institute
Language: English
Subfield: Epidemiology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4410818533